Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRX302 for LUTS Secondary to BPH
NCT01454349Phase 2Completed
- Sponsor
- Sophiris Bio Inc.
- Start
- Sep 2011
- Primary completion
- Mar 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of topsalysin in benign prostatic hyperplasia (BPH), sponsored by Sophiris Bio Inc.. Started Sep 2011; status: completed.
02
Drugs
topsalysin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT01454349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01454349.